×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Module 6: Phase 4 and Life Cycle Management
Session Chair(s)
Courtland R. LaVallee, MBA
Executive Director, Project Management
Dynavax Technologies, United States
Eileen Girten, MS
Director, Medical Writing
Pfizer Inc, United States
- Product Life Cycle
- Product Enhancement
- Phase 4Studies
- New Indications
- New Dosage Forms
Have an account?